Immunohistochemical analysis demonstrated strong nuclear STAT6 expression and diffuse CD34 positivity, while epithelial, myoid/myofibroblastic, neural, and synovial sarcoma markers were negative, confirming the diagnosis of SFT. This evidence concerns the gene STAT6 and synovial sarcoma.